Coronavirus: centro de información para profesionales y pacientes

Este es el nuevo punto de información pensado para personal médico y pacientes sobre coronavirus de Elsevier. Aquí encontrará información experta y de calidad para la comunidad científica y los profesionales de la salud sobre el nuevo coronavirus (también denominado COVID-19 y 2019-nCoV)

Todos los recursos son de libre acceso para personal sanitario y pacientes.

Seleccione una especialidad

Todas

Cirugía maxilofacial y odontología

Enfermería

Fisioterapia y rehabilitación

INTEGRATED EFFICACY RESULTS FROM THE PHASE 2 AND PHASE 3 STUDIES WITH CAPLACIZUMAB IN PATIENTS WITH ACQUIRED THROMBOTIC THROMBOCYTOPENIC PURPURA

Flora Peyvandi, Spero Cataland, Marie Scully, Paul Coppo, Paul Knoebl, Johanna A. Kremer Hovinga, Ara Metjian, Javier de la Rubia, Katerina Pavenski, Jessica Minkue Mi Edou, Filip Callewaert, Hilde De Winter

10.1016/j.htct.2021.10.1047

Hematol Transfus Cell Ther. 2021;43 Supl 3:S46-7

Open access

Twitter

Facebook

IMMUNE THROMBOCYTOPENIA RELAPSE POST COVID-19 VACCINE IN YOUNG MALE PATIENT

Hana Qasim

10.1016/j.htct.2021.10.1046

Hematol Transfus Cell Ther. 2021;43 Supl 3:S46

Open access

Twitter

Facebook

HEMATOLOGICAL FINDINGS IN COVID-19 AND INSIGHTS TO STEM CELL THERAPY

Ghada ELGohary

10.1016/j.htct.2021.10.1050

Hematol Transfus Cell Ther. 2021;43 Supl 3:S48

Open access

Twitter

Facebook

DOES BLOOD TYPE HAVE AN EFFECT ON THE COURSE OF COVID-19?

Fatma YILMAZ, Murat ALBAYRAK, Abdülkerim YILDIZ, Hacer Berna AFACAN ÖZTÜRK, Senem MARAL, Pınar AKYOL, Merih REİS ARAS, Buğra SAĞLAM, Mesut TIĞLIOĞLU

10.1016/j.htct.2021.10.1056

Hematol Transfus Cell Ther. 2021;43 Supl 3:S50

Open access

Twitter

Facebook

RECURRENT AUTOIMMUNE HEMOLYTIC ANEMIA AFTER MRNA COVID-19 VACCINE (PFIZER-BIONTECH)

Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM

10.1016/j.htct.2021.10.1057

Hematol Transfus Cell Ther. 2021;43 Supl 3:S50

Open access

Twitter

Facebook

A RARE ASSOCIATION IN A CASE WITH HEREDITARY SPHEROCYTOSIS: SPECTRIN BETA (SPTB) AND JAK-2 MUTATION

Fatma YILMAZ, Murat ALBAYRAK, Merih REİS ARAS, Senem MARAL, Hacer Berna AFACAN ÖZTÜRK, Pınar TIĞLIOĞLU, Mesut TIĞLIOĞLU, Buğra SAĞLAM

10.1016/j.htct.2021.10.1060

Hematol Transfus Cell Ther. 2021;43 Supl 3:S51

Open access

Twitter

Facebook

WHAT HAVE WE EXPERIENCED WITH COVID-19 IN PATIENTS WITH HEMATOLOGICAL DISORDERS?

Simge ERDEM, Metban MASTANZADE, Mustafa Murat OZBALAK, Sevda SERT EKINCI, Dilek Ozden OZLUK, Tarık Onur TIRYAKI, Beyza OLUK, Ipek YONAL HINDILERDEN, Mustafa Nuri YENEREL, Meliha NALCACI, Tufan TUKEK, Sevgi KALAYOGLU BESISIK

10.1016/j.htct.2021.10.1063

Hematol Transfus Cell Ther. 2021;43 Supl 3:S52

Open access

Twitter

Facebook

How to COVID pandemic changed clinical practice

Medine Yılmaz

10.1016/j.htct.2021.11.007

Hematol Transfus Cell Ther. 2021;43 Supl 3:S69

Open access

Twitter

Facebook

Has the COVID-19 pandemic had a positive impact on scientific production in medical education? A bibliometric analysis

Yeimer Ortiz-Martínez, Carolina Mejía-Alzate, Elizabeth Marquez-Alfonso, Dayana Felizzola-Martínez, María J. Díaz-Ruiz, Rubén Vergara-Retamoza, Eiver Sanes-Peña

10.1016/j.edumed.2021.04.005

Educación Médica. 2021;22:362

Open access

Twitter

Facebook

Correspondence on “prognostic scores for patients with cirrhosis hospitalized with SARS-CoV-2 infection”

Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

10.1016/j.aohep.2021.100360

Ann Hepatol. 2021;25C:

Open access

Twitter

Facebook

Anterior 518 519 520 Página 521 522 523 524 525 Siguiente

Arriba